UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000031122
Receipt No. R000035544
Official scientific title of the study Evaluation of sleep-improving effects of a food
Date of disclosure of the study information 2018/02/03
Last modified on 2018/08/09 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of sleep-improving effects of a food
Title of the study (Brief title) Evaluation of sleep-improving effects of a food
Region
Japan

Condition
Condition Healthy subjects
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study examines sleep-improving effects of a food containing onion extract.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Electroencephalographic(During 5 day intake),
St. Mary's Hospital Sleep Questionnaire(During 5 day intake)
Key secondary outcomes Salivary amylase(Day before the start,1 day,5 day, 6day),
Sleep diary(From the first day of ingestion of a test food to the last day of the test)

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Oral ingestion of the test food containing onion extract (3 pills/day;5 days),
wash out period (2 days),
Oral ingestion of the test food not containing onion extract (3 pills/day;5 days).
Interventions/Control_2 Oral ingestion of the test food not containing onion extract (3 pills/day;5 days),
wash out period (2 days),
Oral ingestion of the test food containing onion extract (3 pills/day;5 days).
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
50 years-old >
Gender Male and Female
Key inclusion criteria (1)Male and female who don't feel like a good sleep aged 30 to 49 when consent acquisition.
(2)Subjects who have a habit of going to bed before 0 a.m.
(3)Subjects whose Pittsburgh Sleep Quality Index score is over 6.
(4)Subjects who understand the study procedure and agree to participate in the study by giving informed consent prior to the study.
Key exclusion criteria (1)Subjects using medical products.
(2)Subjects who have a habit of ingestion medicine, health-promoting foods, foods for specified health uses, health foods that may involve this study.
(3)Subjects who have a history of heart failure,liver failure, kidney failure,digestive system disease.
(4)Subjects whose hay fever is under treatment.
(5)Subjects who use pacemaker.
(6)Subjects whose skin is sensitive and develop a rash by adhesive bandage.
(7)Females who are pregnant or lactating, or who could become pregnant or lactating during test period.
(8)Subjects who excessively take alcohol.
(9)Subjects whose eating habits and rhythm of daily life are irregular (Shifts workers, late-night workers).
(10)Subjects who have a habit of taking onion over 200g/day.
(11)Subjects who have allergy for medicine and foods.
(12)Subjects whose BMI is over 30.
(13)Subjects who are diagnosed with Sleep apnea syndrome, who are aware of being apena during sleep.
(14)Subjects who cannot use Sleep Scope during the test period.
(15)Subjects who plan to go on a trip with lodging during the test period.
(16)Subjects who cannot give up drinking alcohol during the test period.
(17)Subjects who have a history of sleep disorder.
(18)Subjects using medical products for sleep disorder.
(19)Subjects who plan to participate in other clinical tests.
(20)Subjects who are not eligible for this study for some medical reasons.
Target sample size 30

Research contact person
Name of lead principal investigator Fujiwara Suguru
Organization CPCC Company Limited
Division name Clinical Research Planning Department
Address 4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN
TEL 03-5297-3112
Email cpcc-contact@cpcc.co.jp

Public contact
Name of contact person Makoto Ichinohe
Organization CPCC Company Limited
Division name Plan Sales Department
Address 4F Chusin Building, 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047, JAPAN
TEL 03-5297-3112
Homepage URL
Email cpcc-contact@cpcc.co.jp

Sponsor
Institute CPCC Company Limited
Institute
Department

Funding Source
Organization Nisshin Seifun Group Inc.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 01 Month 17 Day
Anticipated trial start date
2018 Year 02 Month 03 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
2018 Year 06 Month 29 Day
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 02 Month 02 Day
Last modified on
2018 Year 08 Month 09 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035544